Oncology
QUASAR-BRCA1/2
The testing kit is designed to detect germline and somatic mutations in the BRCA1, BRCA2 genes by NGS-sequencing and is recommended for determining predisposition to developing hereditary forms of breast cancer, ovarian cancer in healthy women, and when examining patients diagnosed with breast cancer and ovarian cancer in order to determination of effective treatment tactics.
HRR-SCREENING
The kit is designed to detect 16 germline mutations in the HRR genes and is used in screening for predisposition to breast, ovarian, prostate, pancreatic, and stomach cancer.
BRCA1,2-DIAGNOSTICS
The gene expression kit is designed to detect 16 germline mutations in the BRCA1 and BRCA2 genes.
BRCA1,2-TISSUE
The gene expression kit is designed to detect 16 somatic mutations in the BRCA1 and BRCA2 genes.
TEST-BRAF-TISSUE-MULTI
The reagent kit is designed for examination of patients diagnosed with melanoma, papillary thyroid cancer, ovarian, colorectal and prostate cancer in order to determine an effective strategy for targeted therapy.
TEST-BRAF-KRAS-TISSUE
The reagent kit is designed for determination of BRAF and KRAS genes mutation status and is used for patients examination diagnosed with tumor diseases, mainly lung cancer, in order to determine an effective strategy for targeted therapy, predict or monitor the response to cancer therapy and the risk of recurrence or metastasis, regardless of the disease stage in all population gropus.